“Cancer Vaccine” Science-Research, December 2021 — summary from Europe PMC, PubMed and NCBI Gene

Europe PMC — summary generated by Brevi Assistant

Therapeutic cancer injections should generate durable tumor-specific T cell responses. Taken together, we suggest a protein-based all-in-one TCV platform that intracellularly co-delivers growth antigen and inflammasome activator to DCs to induce long-lasting anti-tumor T cell responses. In our previous research, immunoinformatic tools were utilized to design a unique multiepitope cancer vaccine based upon the most immunodominant regions of BORIS cancer-testis antigen. Here, the DNA series of the final vaccine construct was placed right into the pcDNA3. 1 vector as a DNA vaccine. Purpose: this research aimed to analyze the effect of coronavirus condition 2019 fear and associated variables on attitude towards COVID-19 vaccine in cancer patients. Decreasing negative perspectives in the direction of vaccinations will more than likely be accomplished by elevating understanding in the cancer population concerning the COVID-19 vaccine. Goal To explore willingness/hesitancy to immunize self and youngsters against serious intense respiratory disorder coronavirus 2 among caregivers of childhood cancer survivors. The mean time from CCS diagnosis to study completion was one decade. DCP-001 is a cell-based cancer vaccine generated by differentiation and maturation of cells from the human DCOne myeloid leukemic cell line. Direct cell-cell interactions and uptake of DCP-001 cellular content by APCs were shown to depend upon DCP-001 cell surface expression of calreticulin and phosphatidylserine, while clog of CD47 enhanced the process. Cervical cancer is the third most common cancer internationally, with high death when left unattended. Recognizing the acceptability of the HPV vaccine and the obstacles to vaccination is very important for guaranteeing that HPV vaccination programs are successful.

Please keep in mind that the text is machine-generated by the Brevi Technologies’ Natural language Generation model, and we do not bear any responsibility. The text above has not been edited and/or modified in any way.

Source texts:

PubMed — summary generated by Brevi Assistant

In our previous research study, immunoinformatic tools were used to make a novel multiepitope cancer vaccine based on one of the most immunodominant regions of BORIS cancer-testis antigen. Herein, the DNA sequence of the last vaccine construct was placed into the pcDNA3. 1 vector as a DNA vaccine. The anti-tumor impacts of prophylactic co-immunization with these DNA and healthy protein cancer injections were assessed in the metastatic non-immunogenic 4T1 mammary carcinoma in BALB/c mice. Objective: This research study is intended to analyze the effect of coronavirus illness 2019 fear and associated aspects on mindset towards COVID-19 vaccine in cancer patients. Techniques: A possible cross-sectional detailed study was performed with 300 grown-up patients utilizing a verified COVID-19 Phobia Scale and related survey to establish the aspects impacting vaccine acceptance between May-June 2021. Lessening negative mindsets towards vaccinations will more than likely be attained by elevating understanding in the cancer population regarding COVID-19 vaccine. DCP-001 is a cell-based cancer vaccine created by differentiation and maturation of cells from the human DCOne myeloid leukemic cell line. Straight cell-cell interactions and uptake of DCP-001 cellular content by APCs were shown to rely on DCP-001 cell surface area expression of calreticulin and phosphatidylserine, while blockade of CD47 boosted the process. The boosted uptake of DCP-001 by obstructing CD47 rationalizes the possible combination of DCP-001 vaccination with CD47 blocking treatments.

Please keep in mind that the text is machine-generated by the Brevi Technologies’ Natural language Generation model, and we do not bear any responsibility. The text above has not been edited and/or modified in any way.

Source texts:

NCBI Gene — summary generated by Brevi Assistant

This gene encodes a participant of the skin development aspect receptor family of receptor tyrosine kinases. Allelic variations at amino acid positions 654 and 655 of isoform a have been reported, with one of the most typical allele, Ile654/Ile655, revealed below. HLA-DQA1 belongs to the HLA course II alpha chain paralogues. Within the DQ particle, both the alpha chain and the beta chain contain the polymorphisms specifying the peptide binding uniqueness, causing as many as four different particles. HLA-DRB1 belongs to the HLA class II beta chain paralogs. Within the DR molecule, the beta chain consists of all the polymorphisms defining the peptide binding uniqueness. Telomerase is a ribonucleoprotein polymerase that maintains telomere ends by addition of the telomere repeat TTAGGG. Research on mouse suggests that telomerase takes part in chromosomal repair work, since afresh synthesis of telomere repeats may take place at double-stranded breaks. This gene encodes a tumor suppressor protein containing transcriptional activation, DNA binding, and oligomerization domains. Additional isoforms have additionally been revealed to result from making use of alternate translation initiation codons from the same transcript variants.

Please keep in mind that the text is machine-generated by the Brevi Technologies’ Natural language Generation model, and we do not bear any responsibility. The text above has not been edited and/or modified in any way.

Source texts:

Brief Info about Brevi Assistant

The Brevi assistant is a novel way to automatically summarize, assemble, and consolidate multiple text documents, research papers, articles, publications, reports, reviews, feedback, etc., into one compact abstractive form.

At Brevi Assistant, we integrated the most popular open-source databases to empower Researchers, Teachers, and Students to find relevant Contents/Abstracts and to always be up to date about their fields of interest.

Also, users can automate the topics and sources of interest to receive weekly or monthly summaries.

--

--

--

Brevi assistant is the world’s first AI technology able to summarize various document types about the same topic with complete accuracy.

Love podcasts or audiobooks? Learn on the go with our new app.

Recommended from Medium

“Metal Complexes” Science-Research, September 2021, Week 3 — summary from NASA Technology Transfer…

“Nucleus” Science-Research, August 2021 — summary from Astrophysics Data System and DOE Pages

Richard J Stoner: The Father of Modern Aeroponics

Activation Energy: Connecting scientists with new technologies

“Quantum Computing” Science-Research, October 2021, Week 3 — summary from Arxiv and Astrophysics…

“Drought” Science-Research, April 2022, Week 2 — summary from Wiley Online Library

“Proteomics” Science-Research, December 2021, Week 4 — summary from Springer Nature, DOAJ, NCBI…

Feeding the potential: chicken and the egg story of dairy farms.

Get the Medium app

A button that says 'Download on the App Store', and if clicked it will lead you to the iOS App store
A button that says 'Get it on, Google Play', and if clicked it will lead you to the Google Play store
Brevi Assistant

Brevi Assistant

Brevi assistant is the world’s first AI technology able to summarize various document types about the same topic with complete accuracy.

More from Medium

IRON-AIR BATTERY

Sustainability: “Work in Progress”

Sustainability Development Goals

What Makes James Webb Telescope so Discussed

A new exoplanet: meet GJ 367b, an iron planet smaller and denser than Earth